Extended Data Table 2 Representativeness of study participants

From: First-line talazoparib with enzalutamide in HRR-deficient metastatic castration-resistant prostate cancer: the phase 3 TALAPRO-2 trial

  1. *Bicalutamide, flutamide, nilutamide, cyproterone acetate.
  2. HRR denotes homologous recombination repair.
Back to article page